Viewing StudyNCT05918055



Ignite Creation Date: 2024-05-06 @ 7:09 PM
Last Modification Date: 2024-10-26 @ 3:01 PM
Study NCT ID: NCT05918055
Status: RECRUITING
Last Update Posted: 2024-07-10
First Post: 2023-06-23

Brief Title: Eltanexor KPT-8602 With Inqovi Decitabine-Cedazuridine in High-Risk Myelodysplastic Syndromes
Sponsor: National Cancer Institute NCI
Organization: National Institutes of Health Clinical Center CC

Key Dates - Follows AllAPIJSON File Order

Start Date: 2023-11-14
Start Date Type: ACTUAL
Primary Completion Date: 2027-04-05
Primary Completion Date Type: ESTIMATED
Completion Date: 2027-07-05
Completion Date Type: ESTIMATED
First Submit Date: 2023-06-23
First Submit QC Date: June 23 2023
Study First Post Date: 2023-06-26
Study First Post Date Type: ACTUAL
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2024-09-27
Last Update Post Date: 2024-07-10
Last Update Post Date Type: ACTUAL